566 related articles for article (PubMed ID: 26675038)
21. [Laboratory detection of carbapenemase-producing Enterobacteriaceae].
Cercenado E
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():8-11. PubMed ID: 26365726
[TBL] [Abstract][Full Text] [Related]
22. [ESBL and carbapenemases in Enterobacteriaceae].
Cherkaoui A; Emonet S; Renzi G; Riat A; Greub G; Schrenzel J
Rev Med Suisse; 2014 Nov; 10(450):2142-8. PubMed ID: 25549375
[TBL] [Abstract][Full Text] [Related]
23. Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.
Marimuthu K; Ng OT; Cherng BPZ; Fong RKC; Pada SK; De PP; Ooi ST; Smitasin N; Thoon KC; Krishnan PU; Ang MLT; Chan DSG; Kwa ALH; Deepak RN; Chan YK; Chan YFZ; Huan X; Zaw Linn K; Tee NWS; Tan TY; Koh TH; Lin RTP; Hsu LY; Sengupta S; Paterson DL; Perencevich E; Harbarth S; Teo J; Venkatachalam I;
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383670
[TBL] [Abstract][Full Text] [Related]
24. Carbapenemase-producing enterobacteriaceae (CPE) in the pediatric setting: results from an 18-month survey.
Colombo S; Scolfaro C; Calitri C; Denina M; Carraro F; De Intinis G; Tovo PA
Infect Control Hosp Epidemiol; 2014 May; 35(5):599-601. PubMed ID: 24709738
[No Abstract] [Full Text] [Related]
25. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
Goodman KE; Simner PJ; Tamma PD; Milstone AM
Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959
[TBL] [Abstract][Full Text] [Related]
26. Carbapenem non-susceptible enterobacteriaceae in Quebec, Canada: results of a laboratory surveillance program (2010-2012).
Lefebvre B; Lévesque S; Bourgault AM; Mulvey MR; Mataseje L; Boyd D; Doualla-Bell F; Tremblay C
PLoS One; 2015; 10(4):e0125076. PubMed ID: 25910041
[TBL] [Abstract][Full Text] [Related]
27. Mobilization of Carbapenemase-Mediated Resistance in Enterobacteriaceae.
Mathers A
Microbiol Spectr; 2016 Jun; 4(3):. PubMed ID: 27337454
[TBL] [Abstract][Full Text] [Related]
28. Performance of CarbaNP and CIM tests in OXA-48 carbapenemase-producing Enterobacteriaceae.
Yıldız SS; Kaşkatepe B; Avcıküçük H; Öztürk Ş
Acta Microbiol Immunol Hung; 2017 Mar; 64(1):9-16. PubMed ID: 28357923
[TBL] [Abstract][Full Text] [Related]
29. Detection and epidemiology of carbapenemase producing Enterobacteriaceae in the Netherlands in 2013-2014.
Vlek AL; Frentz D; Haenen A; Bootsma HJ; Notermans DW; Frakking FN; de Greeff SC; Leenstra T;
Eur J Clin Microbiol Infect Dis; 2016 Jul; 35(7):1089-96. PubMed ID: 27126332
[TBL] [Abstract][Full Text] [Related]
30. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).
Deshpande LM; Jones RN; Fritsche TR; Sader HS
Microb Drug Resist; 2006; 12(4):223-30. PubMed ID: 17227206
[TBL] [Abstract][Full Text] [Related]
31. Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014.
Mataseje LF; Abdesselam K; Vachon J; Mitchel R; Bryce E; Roscoe D; Boyd DA; Embree J; Katz K; Kibsey P; Simor AE; Taylor G; Turgeon N; Langley J; Gravel D; Amaratunga K; Mulvey MR
Antimicrob Agents Chemother; 2016 Nov; 60(11):6787-6794. PubMed ID: 27600052
[TBL] [Abstract][Full Text] [Related]
32. The threat of carbapenem-resistant Enterobacteriaceae in Lebanon: an update on the regional and local epidemiology.
El-Herte RI; Kanj SS; Matar GM; Araj GF
J Infect Public Health; 2012 Jun; 5(3):233-43. PubMed ID: 22632597
[TBL] [Abstract][Full Text] [Related]
33. Epidemiological, clinical, and microbiological characteristics of carbapenemase-producing Enterobacteriaceae bloodstream infection in the Republic of Korea.
Park JW; Lee H; Park SY; Kim TH
Antimicrob Resist Infect Control; 2019; 8():48. PubMed ID: 30873279
[TBL] [Abstract][Full Text] [Related]
34. [Carbapenemase producing Enterobacteriaceae in the Netherlands: unnoticed spread to several regions].
Leenstra T; Bosch T; Vlek AL; Bonten MJM; van der Lubben IM; de Greeff SC
Ned Tijdschr Geneeskd; 2017; 161():D1585. PubMed ID: 29076442
[TBL] [Abstract][Full Text] [Related]
35. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge.
Nordmann P
Med Mal Infect; 2014 Feb; 44(2):51-6. PubMed ID: 24360201
[TBL] [Abstract][Full Text] [Related]
36. Breakpoints for carbapenemase-producing Enterobacteriaceae: is the problem solved?
Cantón R; Canut A; Morosini MI; Oliver A
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():33-40. PubMed ID: 25542050
[TBL] [Abstract][Full Text] [Related]
37. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.
Deshpande P; Rodrigues C; Shetty A; Kapadia F; Hedge A; Soman R
J Assoc Physicians India; 2010 Mar; 58():147-9. PubMed ID: 20848811
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK).
Woodford N; Xu-McCrae L; Mushtaq S; Wu HHT; Ellington MJ; Lancaster O; Davies F; Donaldson H; Rao GG; Verma A; Wareham DW; Ciesielczuk H; Stone GG; Irani PM; Bracher S; Hawkey PM
J Antimicrob Chemother; 2018 Mar; 73(3):698-702. PubMed ID: 29253163
[TBL] [Abstract][Full Text] [Related]
39. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe.
Cantón R; Akóva M; Carmeli Y; Giske CG; Glupczynski Y; Gniadkowski M; Livermore DM; Miriagou V; Naas T; Rossolini GM; Samuelsen Ø; Seifert H; Woodford N; Nordmann P;
Clin Microbiol Infect; 2012 May; 18(5):413-31. PubMed ID: 22507109
[TBL] [Abstract][Full Text] [Related]
40. Non-molecular detection of carbapenemases in Enterobacteriaceae clinical isolates.
Aguirre-Quiñonero A; Martínez-Martínez L
J Infect Chemother; 2017 Jan; 23(1):1-11. PubMed ID: 27769646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]